Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1984;64:451-458
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MclNDOE, W. A.
Right arrow Articles by MULLINS, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MclNDOE, W. A.
Right arrow Articles by MULLINS, P. R.

The Invasive Potential of Carcinoma In Situ of the Cervix

WILLIAM A. MclNDOE, MD, MALCOLM R. McLEAN, MD, RONALD W. JONES, MD and PETER R. MULLINS, MSc

From the National Women's Hospital, and the Department of Community Health, University of Auckland, Auckland, New Zealand

Abstract

Nine hundred and forty-eight patients with carcinoma in situ (CIS) of the cervix diagnosed histologically have been followed from five to 28 years. Among the 817 patients who had normal cytology follow-up, 12 (1.5%) developed invasive carcinoma. A second group of 131 patients continued to produce abnormal cytology consistent with cervical neoplasia, and 29 (22%) of them developed invasive carcinoma of the cervix or vaginal vault. Patients with continuing abnormal cytology after initial management of CIS of the cervix are 24.8 times more likely to develop invasive carcinoma than women who have normal follow-up cytology. Further, when compared with the population at large, the chances of patients with normal follow-up cytology developing invasive cervical or vaginal vault carcinoma increase 3.2-fold over women who have never had CIS of the cervix.




This article has been cited by other articles:


Home page
Sex. Transm. Infect.Home page
R. D Cranston
Anal cancer prevention: how we are failing men who have sex with men
Sex Transm Inf, November 1, 2008; 84(6): 417 - 419.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
D. van Hamont, J. Bulten, H. Shirango, W.J.G. Melchers, L.F.A.G. Massuger, and P.C.M. de Wilde
Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models
Carcinogenesis, April 1, 2008; 29(4): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
R. W. Jones, D. M. Rowan, and A. W. Stewart
Vulvar Intraepithelial Neoplasia: Aspects of the Natural History and Outcome in 405 Women
Obstet. Gynecol., December 1, 2005; 106(6): 1319 - 1326.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. E. Castle, M. Schiffman, D. R. Scott, M. E. Sherman, A. G. Glass, B. B. Rush, J. E. Schussler, S. Wacholder, and A. T. Lorincz
Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1311 - 1314.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. F. Schlecht, R. W. Platt, E. Duarte-Franco, M. C. Costa, J. P. Sobrinho, J. C. M. Prado, A. Ferenczy, T. E. Rohan, L. L. Villa, and E. L. Franco
Human Papillomavirus Infection and Time to Progression and Regression of Cervical Intraepithelial Neoplasia
J Natl Cancer Inst, September 3, 2003; 95(17): 1336 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Sherman, S. S. Wang, R. Tarone, L. Rich, and M. Schiffman
Histopathologic Extent of Cervical Intraepithelial Neoplasia 3 Lesions in the Atypical Squamous Cells of Undetermined Significance Low-grade Squamous Intraepithelial Lesion Triage Study: Implications for Subject Safety and Lead-time Bias
Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 372 - 379.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
J. M. Elwood
Developing Areas in Cancer in New Zealand
Jpn. J. Clin. Oncol., February 1, 2002; 32(90001): S43 - 51.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A Greene and M K Heatley
The appropriateness of examining the entire cervix histologically in hysterectomy specimens from women with a previous history of cervical intraepithelial neoplasia or dyskaryosis
J. Clin. Pathol., February 1, 2001; 54(2): 155 - 157.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. C. Connolly, D. L. Greenspan, R. Wu, X. Ren, R. L. Dunn, K. V. Shah, R. W. Jones, F. X. Bosch, N. Muñoz, and K. R. Cho
Loss of Fhit Expression in Invasive Cervical Carcinomas and Intraepithelial Lesions Associated with Invasive Disease
Clin. Cancer Res., September 1, 2000; 6(9): 3505 - 3510.
[Abstract] [Full Text]


Home page
J. Clin. Pathol.Home page
A M Zaitoun, G McKee, M J Coppen, S M Thomas, and P O G Wilson
Completeness of excision and follow up cytology in patients treated with loop excision biopsy
J. Clin. Pathol., March 1, 2000; 53(3): 191 - 196.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. Paul
Internal and external morality of medicine: lessons from New Zealand
BMJ, February 19, 2000; 320(7233): 499 - 503.
[Full Text]


Home page
Obstet GynecolHome page
C. H. HOLSCHNEIDER, K. GHOSH, and F. J. MONTZ
See-and-Treat in the Management of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Resource Utilization Analysis
Obstet. Gynecol., September 1, 1999; 94(3): 377 - 385.
[Abstract] [Full Text] [PDF]


Home page
Arch Fam MedHome page
K. L. Margolis, L. F. Carson, P. A. Setness, M. W. Stanley, M. J. Henry-Stanley, J. Beneke, B. Linzie, and R. C. McGlennen
Are Benign Cellular Changes on a Papanicolaou Smear Really Benign?: A Prospective Cohort Study
Arch Fam Med, September 1, 1999; 8(5): 433 - 439.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M I Shafi
Controversies in Management: Management of women with mild dyskaryosis Cytological surveillance avoids overtreatment
BMJ, September 3, 1994; 309(6954): 590 - 592.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.